Dose-response relationships for the induction of P450 2B by 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP) in rat and cultured rat hepatocytes

References

• Böhlen P., Stein S., Dairman W., Udenfriend S. Fluorometric assay of proteins in the nanogram range. Archives of Biochemistry and Biophysics 1973; 155: 213–220
   PubMed Web of Science ®Google Scholar
• Boobis A. R., Sesardic D., Murray B. P., Edwards R. J., Singleton A. M., Rich K. J., Murray S., Torre R., De La Segura J., Pelkonen O., Pasanen M., Kobayashi S., Zhi-Guang T., Davies D. S. Species variation in the response of the cytochrome P450-dependent monooxygenase system to inducers and inhibitors. Xenobiotica 1990; 20: 1139–1161
   PubMed Web of Science ®Google Scholar
• Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 1976; 72: 248–254
   PubMed Web of Science ®Google Scholar
• Burke M. D., Thompson S., Elcombe C. R., Halpert J., Haaparanta T., Mayer R. T. Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. Biochemical Pharmacology 1985; 34: 3337–3345
   PubMed Web of Science ®Google Scholar
• Dansette P. M., Du Bois G. C., Jerina D. M. Continuous fluorometric assay of epoxide hydrase activity. Analytical Biochemistry 1979; 97: 340–345
   PubMedGoogle Scholar
• Ding G. J.-F., Lu A. Y. H., Pickett C. B. Rat liver glutathione S-transferases: nucleotide sequence analysis of a Yb1 cDNA clone and prediction of the complete amino acid sequence of the Y1 subunit. Journal of Biological Chemistry 1985; 260: 13268–13271
   PubMed Web of Science ®Google Scholar
• Ding V. D.-H., Cameron R., Pickett C. B. Regulation of microsomal, xenobiotic epoxide hydrolase messenger RNA in persistent hepatocyte nodules and hepatomas induced by chemical carcinogens. Cancer Research 1990; 50: 256–260
   PubMedGoogle Scholar
• Diwan B. A., Lubet R. A., Ward J. M., Hrabie J. A., Rice J. M. Tumor-promoting and hepatocarcinogenic effects of 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP) in DBA/2NCr and C57BL/6NCr mice and an apparent promoting effect on nasal cavity tumors but not on hepatocellular tumors in F344/NCr rats initiated with N-nitrosodiethylamine. Carcinogenesis 1992; 13: 1893–1901
   PubMedGoogle Scholar
• Dragani T. A., Manenti G., Galliani G., Della Porta G. Promoting effects of 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene in mouse hepatocarcinogenesis. Carcinogenesis 1985; 6: 225–228
   PubMed Web of Science ®Google Scholar
• FonnÉ R., Meyer U. A. Mechanisms of phenobarbital-type induction of cytochrome P-450 isozymes. Pharmacology and Therapeutics 1987; 33: 19–22
   PubMedGoogle Scholar
• Hansch C, Sinclair J. F., Sinclair P. R. Induction of cytochrome P450 in chick embryo hepatocytes: a quantitative structure-activity analysis. Quantitative Structure-Activity Relationships 1990; 9: 223–226
   Google Scholar
• Holford N. H. G., Sheiner L. B. Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models. Clinical Pharmacokinetics 1981; 6: 429–453
   PubMed Web of Science ®Google Scholar
• Honkakoski P., Auriola S., Lang M. A. Distinct induction profiles of three phenobarbital-responsive mouse liver cytochrome P450 isozymes. Biochemical Pharmacology 1992; 43: 2121–2128
   PubMed Web of Science ®Google Scholar
• Kelley M., Lambert I., Merrill J., Safe S. 1,4-Bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP) and related compounds as inducers of hepatic monooxygenases. Structure-activity effects. Biochemical Pharmacology 1985; 34: 3489–3494
   Google Scholar
• Kende A. S., Ebetino F. H., Drendel W. B., Sundaralingam M., Glover E., Poland A. Structure-activity relationship of bispyridyloxybenzene for induction of mouse hepatic aminopyrine N-demethylase activity. Molecular Pharmacology 1985; 28: 445–453
   Google Scholar
• Kocarek T. A., Schuetz E. G., Guzelian P. S. Differentiated induction of cytochrome P450b/e and P450p mRNAs by dose of phenobarbital in primary cultures of adult rat hepatocytes. Molecular Pharmacology 1990; 38: 440–444
   PubMed Web of Science ®Google Scholar
• Lubet R. A., Dragnev K. H., Chauhan D. P., Nims R. W., Diwan B. A., Ward J. M., Jones C. R., Rice J. M., Miller M. S. A pleiotropic response to phenobarbital-type enzyme inducers in the F344/NCr rat. Effects of chemicals of varied structure. Biochemical Pharmacology 1992; 43: 1067–1078
   PubMed Web of Science ®Google Scholar
• Lubet R. A., Mayer R. T., Cameron J. W., Nims R. W., Burke M. D., Wolff T., Guengerich F. P. Dealkylation of pentoxyresorufin: a rapid and sensitive assay for measuring induction of cytochrome(s) P-450 by phenobarbital and other xenobiotics in the rat. Archives of Biochemistry and Biophysics 1985a; 238: 43–48
   PubMed Web of Science ®Google Scholar
• Lubet R. A., Nims R. W., Mayer R. T., Cameron J. W., Schechtman L. M. Measurement of cytochrome P-450 dependent dealkylation of alkoxyphenoxazones in hepatic S9s and hepatocyte homogenates: effects of dicumarol. Mutation Research 1985b; 142: 127–131
   PubMed Web of Science ®Google Scholar
• Nims R. W., Beebe L. E., Dragnev K. H., Thomas P. E., Fox S. D., Issaq H. J., Jones C. R., Lubet R. A. Induction of hepatic CYP1A in male F344/NCr rats by dietary exposure to Aroclor 1254: Examination of immunochemical, RNA, catalytic and pharmacokinetic endpoints. Environmental Research 1992; 59: 447–466
   PubMed Web of Science ®Google Scholar
• Nims R. W., Lubet R. A., Jones C. R., Mellini D. W., Thomas P. E. Comparative pharmacodynamics of CYP2B induction by phenobarbital in the male and female F344/NCr rat. Biochemical Pharmacology 1993a; 45: 521–526
   PubMed Web of Science ®Google Scholar
• Nims R. W., Sinclair P. R., Sinclair J. F., Thomas P. E., Jones C. R., Mellini D. W., Syi J.-L., Lubet R. A. Pharmacodynamics of cytochrome P450 2B induction by phenobarbital. 5-ethyl-5-phenylhydantoin, and 5-ethyl-5-phenyloxazolidinedione in the male rat liver and in cultured rat hepatocytes. Chemical Research in Toxicology 1993b; 6: 188–196
   Google Scholar
• Okey A. B. Enzyme induction in the cytochrome P-450 system. Pharmacology and Therapeutics 1990; 45: 241–298
   PubMed Web of Science ®Google Scholar
• Omiecinski C. J., Ramsden R., Rampersaud A., Walz F. G., Jr. Null phenotype for cytochrome P450 2B2 in the rat results from a deletion of its structural gene. Molecular Pharmacology 1992; 42: 249–256
   Google Scholar
• Omiecinski C. J., Walz F. G., Jr., Vlasuk G. P. Phenobarbital induction of rat liver cytochromes P-450b and P-450e. Quantitation of specific RNAs by hybridization to synthetic oligonucleotide probes. Journal of Biological Chemistry 1985; 260: 3247–3250
   PubMed Web of Science ®Google Scholar
• Pickett C. B., Telakowski-Hopkins C. A., Ding G. J.-F., Argenbright L., Lu A. Y. H. Rat liver glutathione S-transferases: complete nucleotide sequence of a glutathione S-transferase mRNA and the regulation of the Ya, Yb, and Yc mRNAs by 3-methylcholanthrene and phenobarbital. Journal of Biological Chemistry 1984; 259: 5182–5188
   PubMed Web of Science ®Google Scholar
• Poland A., Mak I., Glover E. Species differences in responsiveness to 1,4-bis[2-(3,5-dichloropyridyloxy)]-benzene, a potent phenobarbital-like inducer of microsomal monooxygenase activity. Molecular Pharmacology 1981; 20: 442–450
   PubMed Web of Science ®Google Scholar
• Poland A., Mak I., Glover E., Boatman R. J., Ebetino F. H., Kende A. S. 1,4-Bis[2-(3,5-dichloropyridyloxy)]-benzene, a potent phenobarbital-like inducer of microsomal monooxygenase activity. Molecular Pharmacology 1980; 18: 571–580
   PubMed Web of Science ®Google Scholar
• Raunio H., Kojo A., Juvonen R., Honkakoski P., JÄRvinen P., Lang M. A., VÄHÄKangas K., Gelboin H. V., Park S.-S., Pelkonen O. Mouse hepatic cytochrome P-450 isozyme induction by 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene, pyrazole, and phenobarbital. Biochemical Pharmacology 1988; 37: 4141–4147
   PubMedGoogle Scholar
• Reik L. M., Levin W., Ryan D. E., Maines S. L., Thomas P. E. Monoclonal antibodies distinguish among isozymes of the cytochrome P-450b subfamily. Archives of Biochemistry and Biophysics 1985; 242: 365–382
   PubMed Web of Science ®Google Scholar
• Romano M., Esteve A., Coccia P., Masturzo P., Galliani G., Ghezzi P., Salmona M. Biochemical characterization of the hepatic effects in mice and rats of 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene, a hepatic neoplasm promoter. Toxicology and Applied Pharmacology 1986; 83: 379–385
   Google Scholar
• Sinclair P. R., Bement W. J., Haugen S. A., Sinclair J. F., Guzelian P. S. Induction of cytochrome P-450 and 5-aminolevulinate synthase activities in cultured rat hepatocytes. Cancer Research 1990; 50: 5219–5224
   PubMed Web of Science ®Google Scholar
• Smith G., Henderson C. J., Parker M. G., White R., Bars R. G., Wolf C. R. 1,4-Bis[2-(3,5-dichloropyridyloxy)]benzene, an extremely potent modulator of mouse hepatic cytochrome P-450 gene expression. Biochemical Journal 1993; 289: 807–813
   PubMed Web of Science ®Google Scholar
• Sonderfan A. J., Arlotto M. P., Dutton D. R., Mc Millen S. K., Parkinson A. Regulation of testosterone hydroxylation by rat liver microsomal cytochrome P-450. Archives of Biochemistry and Biophysics 1987; 255: 27–41
   PubMed Web of Science ®Google Scholar
• Srivastava G., Hansen A. J., Bawden M. J., May B. K. Hemin administration to rats reduces levels of hepatic mRNAs for phenobarbitone-inducible enzymes. Molecular Pharmacology 1990; 38: 486–493
   PubMed Web of Science ®Google Scholar
• Waxman D. J., Azaroff L. Phenobarbital induction of cytochrome P-450 gene expression. Biochemical Journal 1992; 281: 577–592
   PubMed Web of Science ®Google Scholar
• Whitlock J. P., Jr. The regulation of cytochrome P-450 gene expression. Annual Reviews in Pharmacology and Toxicology 1986; 26: 333–369
   PubMed Web of Science ®Google Scholar